{"id":130726,"date":"2022-06-20T10:01:07","date_gmt":"2022-06-20T14:01:07","guid":{"rendered":"https:\/\/44.250.171.167\/?p=130726"},"modified":"2022-10-06T04:23:14","modified_gmt":"2022-10-06T08:23:14","slug":"aether-industries-ltd-q4-fy22-earnings-conference-call-insights","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/aether-industries-ltd-q4-fy22-earnings-conference-call-insights\/","title":{"rendered":"Aether Industries Ltd Q4 FY22 Earnings Conference Call Insights"},"content":{"rendered":"

Key highlights from Aether Industries Ltd (AETHER<\/a>) Q4 FY22 Earnings Concall<\/strong><\/h2>\n

\u00a0<\/strong><\/p>\n

Q&A Highlights:<\/strong><\/h3>\n

Gagan Thareja – ASK Investment Managers – Analyst<\/strong><\/p>\n

    \n
  • Would growth get constrained due to lack of capacity for the first 3 quarters of FY23?<\/li>\n<\/ul>\n

    Rohan Desai – Whole-time Director<\/strong><\/p>\n

      \n
    • Currently at 80% of utilization.<\/li>\n
    • Constantly debottlenecking plants.\n
        \n
      • Rearranging equipment to increase capacity.<\/li>\n<\/ul>\n<\/li>\n
      • Expects to reach 90-92% capacity in FY23.<\/li>\n<\/ul>\n

        \u00a0<\/strong><\/p>\n

        Gagan Thareja – ASK Investment Managers – Analyst<\/strong><\/p>\n

          \n
        • Breakdown of sales growth into volume growth and price of sales mix for FY22?<\/li>\n<\/ul>\n

          Rohan Desai – Whole-time Director<\/strong><\/p>\n

            \n
          • Price increased by only 1.5-2% on an avg. overall.<\/li>\n
          • Whole growth in FY22 was due to volume.<\/li>\n<\/ul>\n

            \u00a0<\/strong><\/p>\n

            Gagan Thareja – ASK Investment Managers – Analyst<\/strong><\/p>\n

              \n
            • What\u2019s the additional capacity given by the two new plants under construction, and operational and utilization time frame.<\/li>\n<\/ul>\n

              Rohan Desai – Whole-time Director<\/strong><\/p>\n

                \n
              • Site 4 gets operationalized towards end of FY23 and site 5 towards the end of FY24.<\/li>\n
              • Both units combined would give 9,000 metric tons manufacturing capacity.<\/li>\n
              • To be optimally utilized in two years once commissioned.<\/li>\n<\/ul>\n

                \u00a0<\/strong><\/p>\n

                Yash Shah – Investec India – Analyst<\/strong><\/p>\n

                  \n
                • Product portfolio outlook over the next five years?<\/li>\n<\/ul>\n

                  Rohan Desai – Whole-time Director<\/strong><\/p>\n

                    \n
                  • Will continue to add products in the pharma and agro.<\/li>\n
                  • The eventual goal is to balance out all the buckets and make it equitable.\n
                      \n
                    • Expects non-pharma, non-agro sectors to rise in future.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

                      \u00a0<\/strong><\/p>\n

                      Yash Shah – Investec India – Analyst<\/strong><\/p>\n

                        \n
                      • IPO proceeds utilization and capex for FY23.<\/li>\n<\/ul>\n

                        Faiz Nagariya \u2013 CFO<\/strong><\/p>\n

                          \n
                        • Started using the IPO proceeds; paid off the loans.<\/li>\n
                        • Total capex is expected to be INR200 crore.<\/li>\n<\/ul>\n

                          \u00a0\u00a0<\/strong><\/p>\n

                          Nitesh Dhoot – Prabhudas Lilladher – Analyst <\/strong><\/p>\n

                            \n
                          • Reason for 18% decline in employee cost in 4Q on a sequential basis and other expenses declining 9%?<\/li>\n<\/ul>\n

                            Faiz Nagariya – CFO<\/strong><\/p>\n

                              \n
                            • Employee costs have been capitalized for the R&D and new plants that are coming up.<\/li>\n
                            • Other expense declining is due to the plant commissioned in Jan. 2021, which is now in-house and there is lot of savings in costs.<\/li>\n<\/ul>\n

                              \u00a0<\/strong><\/p>\n

                              Nityanand Parakh – Individual Investor – Analyst<\/strong><\/p>\n

                                \n
                              • Vision for next 3-5 years in terms of new products.<\/li>\n<\/ul>\n

                                Rohan Desai – Whole-time Director<\/strong><\/p>\n

                                  \n
                                • Going to launch 5 new products in FY23; advance intermediates.<\/li>\n
                                • In future would maintain the same rate of product introductions.<\/li>\n<\/ul>\n

                                  \u00a0<\/strong><\/p>\n

                                  Nityanand Parakh – Individual Investor – Analyst<\/strong><\/p>\n

                                    \n
                                  • Is the new capacity fungible or a dedicated capacity for some products.<\/li>\n<\/ul>\n

                                    Rohan Desai – Whole-time Director<\/strong><\/p>\n

                                      \n
                                    • All of AETHER\u2019s manufacturing facilities are fungible and multipurpose across the core competencies it\u2019s designed for.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

                                      Key highlights from Aether Industries Ltd (AETHER) Q4 FY22 Earnings Concall \u00a0 Q&A Highlights: Gagan Thareja – ASK Investment Managers – Analyst Would growth get constrained due to lack of capacity for the first 3 quarters of FY23? Rohan Desai – Whole-time Director Currently at 80% of utilization. Constantly debottlenecking plants. Rearranging equipment to increase […]<\/p>\n","protected":false},"author":1767,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[9825,392],"tags":[8519],"class_list":["post-130726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings-call-highlights","category-earnings","tag-chemicals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":139291,"url":"https:\/\/alphastreet.com\/india\/solara-active-pharma-sciences-limited-solara-q3-fy23-earnings-concall-transcript\/","url_meta":{"origin":130726,"position":0},"title":"Solara Active Pharma Sciences Limited (SOLARA) Q3 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"January 26, 2023","format":false,"excerpt":"Solara Active Pharma Sciences Limited (NSE:SOLARA) Q3 FY23 Earnings Concall dated Jan. 25, 2023. Corporate Participants: Abhishek Singhal\u00a0--\u00a0Investor Relations Consultant Jitesh Devendra\u00a0--\u00a0Managing Director S. Hariharan\u00a0--\u00a0Executive Director and Chief Financial Officer Analysts: Unidentified Participant\u00a0--\u00a0-- Analyst Mahek Talati\u00a0--\u00a0YellowJersey Investment Advisors -- Analyst Tushar Manudhane\u00a0--\u00a0Motilal Oswal Financial Service Ltd. -- Analyst Nitin Agarwal\u00a0--\u00a0DAM\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":129970,"url":"https:\/\/alphastreet.com\/india\/indiabulls-housing-finance-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":130726,"position":1},"title":"Indiabulls Housing Finance Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"May 24, 2022","format":false,"excerpt":"https:\/\/youtu.be\/7L73vvsI86c Key highlights from Indiabulls Housing Finance Ltd (IBULHSGFIN) Q4 FY22 Earnings Concall Q&A Highlights: Kang Zheng of Tahan Capital Management asked if the company has seen any impact on rate of disbursement due to the HDFC Bank merger. Gagan Banga, MD said the merger is a large opportunity, especially\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130743,"url":"https:\/\/alphastreet.com\/india\/international-conveyors-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":130726,"position":2},"title":"International Conveyors Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 21, 2022","format":false,"excerpt":"Key highlights from International Conveyors Ltd (INTLCONV) Q4 FY22 Earnings Concall \u00a0 Q&A Highlights: Muzammil Usmani \u2013 Paramount - Analyst Replacement and the new demand from the revenue generated and outlook? Prasad Deshpande \u2013 ED Each mines have their own blocks and they also explore new blocks. As on date,\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":130874,"url":"https:\/\/alphastreet.com\/india\/salasar-techno-engineering-ltd-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":130726,"position":3},"title":"Salasar Techno Engineering Ltd Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"June 28, 2022","format":false,"excerpt":"https:\/\/youtu.be\/WLjIHDHmuFY Key highlights from Salasar Techno Engineering Ltd (SALASAR) Q4 FY22 Earnings Concall Q&A Highlights: Viral Shah of YES Securities asked about the bid pipeline. Shashank Agarwal MD replied that the company has become selective in bidding the tenders as of now as it has a good order book in\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":137790,"url":"https:\/\/alphastreet.com\/india\/kaveri-seed-co-ltd-kscl-q2-fy23-earnings-concall-transcript\/","url_meta":{"origin":130726,"position":4},"title":"KAVERI SEED CO LTD (KSCL) Q2 FY23 Earnings Concall Transcript","author":"IRS_INDIA","date":"November 15, 2022","format":false,"excerpt":"KAVERI SEED CO LTD (NSE:KSCL) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Mithun Chand -- Whole Time Director Analysts: Guneet Singh -- CCIPL -- Analyst Anurag Jain -- -- Analyst Agam Shah -- Rspn Ventures -- Analyst Sanjeev Zarbade -- DreamLadder Investment Advisors -- Analyst Yogesh Tiwari\u2026","rel":"","context":"In "Earnings Call Transcripts"","block_context":{"text":"Earnings Call Transcripts","link":"https:\/\/alphastreet.com\/india\/category\/transcripts\/"},"img":{"alt_text":"Earnings Conference Call Transcript","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/09\/Transcript-thumbnail-e1657213425955.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":128245,"url":"https:\/\/alphastreet.com\/india\/gufic-biosciences-limited-q3-fy22-earnings-conference-call-insights\/","url_meta":{"origin":130726,"position":5},"title":"Gufic Biosciences Limited Q3 FY22 Earnings Conference Call Insights","author":"Praveen","date":"March 14, 2022","format":false,"excerpt":"https:\/\/youtu.be\/f3tlyxhD91U Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY22 Earnings Concall Management Update: In CDMO, GUFICBIO said it\u2019s looking at a 9.4 million vials capacity per month which should make the company the largest manufacturer in the world. Q&A Highlights: Umang Shah from Sarath Capital AIF asked that the\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/130726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1767"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=130726"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/130726\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=130726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=130726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=130726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}